Root’s stock price has taken a beating over the past six months, shedding 30.2% of its value and falling to $89.76 per share. This may have investors wondering how to approach the situation.

Background: Determining optimal timing for intensifying the frequency of physician encounters for type 2 diabetes mellitus (T2DM) requires trade-offs between timely care and clinician burden. We aimed ...